Advertisement

Topics

FDA accepts Novartis' application for AMD drug

06:31 EDT 16 Apr 2019 | SmartBrief

The FDA accepted under priority review status Novartis' biologics license application for brolucizumab, being developed to tr -More

Original Article: FDA accepts Novartis' application for AMD drug

NEXT ARTICLE

More From BioPortfolio on "FDA accepts Novartis' application for AMD drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...